Last reviewed · How we verify
Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
Approved treatments
- Rybrevant · Johnson & Johnson
Amivantamab-vmjw targets EGFR and MET, disrupting their signaling and enhancing immune cell-mediated destruction of tumor cells. - Exkivity · Takeda
- RYBREVANT · JANSSEN BIOTECH
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations patent landscape — cliff calendar, originator estates, attackable patents
- Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations treatment landscape brief
- Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations treatment updates RSS
Frequently asked questions about Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
What drugs treat Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations?
Tracked treatments include Rybrevant, Exkivity, RYBREVANT.
What is the treatment for Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations?
Standard treatment for Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations includes Rybrevant, Exkivity, RYBREVANT. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations patent cliff · Advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations CI report
- Treatment: Rybrevant · Johnson & Johnson
- Treatment: Exkivity · Takeda
- Treatment: RYBREVANT · JANSSEN BIOTECH
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing